Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

Abstract
Department of Defense Breast Cancer Program (Knutson). NIH grants, the National Cancer Institute (R01 CA75163), and the Department of Defense Breast Cancer Program (Dsis). NIH grant MO1-RR-00037.

This publication has 43 references indexed in Scilit: